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derestimates true stenosis severity, oversimpliﬁes the relationship
with systolic aortic pressure and potentially denies patients the
opportunity for appropriate revascularization.
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Abstract nos: 43 - 50Table. 8-mo follow-up OCT ﬁndings
Variables
Late phase SM
(22)
No Late phase SM
(63) P
Average NIT (mm) 60.6626.86 90.8236.03 0.001
% Uncovered strut
(%)
2.453.13 0.591.38 <0.001
IS-Th (%) 5 (22.7) 1 (1.6) 0.004
Variables
LASM
(17)
No LASM
(68) P
Average NIT (mm) 63.2029.63 88.036.26 0.011
% Uncovered strut
(%)
2.583.47 0.691.45 0.001
IS-Th (%) 4 (23.5) 2 (2.9) 0.013
NIT: Neoointimal thicknessTCT-43
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BACKGROUND Drug eluting stent (DES) thrombosis may be triggered
by different phenomenon that require speciﬁc treatment and can vary
according to the device properties. However, angiography alone is
frequently limited to correctly identify these mechanisms. The pre-
sent work aimed to investigate and compare the characteristics and
mechanisms of stent thrombosis (ST) between 1st (paclitaxel -and
sirolimus-eluting stents) and 2nd generation (everolimus- and zotar-
alimus eluting stents) among a large cohort of patients explored by
optical coherence tomography (OCT).
METHODS The PESTO study was a prospective national registry
involving 29 French catheterization labs. Patients with acute coronary
syndromes (ACS) were prospectively screened for presence of deﬁnite
ST and explored by OCT after culprit lesion deocclusion. ST was
classiﬁed as acute (AST), sub-acute (SAST), late (LST) and very late
(VLST). Baseline clinical, biological and angiographic characteristics
were collected for each subject. Three independent operators un-
aware of patients’ characteristics reviewed OCT data to identify the ST
etiologies.
RESULTS The ﬁnal analysis involved n¼69 subjects (age 62.01.5 y,
90% male), including n¼34 patients with 1st generation DES (DES1g)
and n¼35 patients with 2nd generation DES (DES2g). VLST was the
clinical presentation in 80 %, LST in 3 % and SAST+AST in 17 % of
the patients. The delay between initial PCI and ST was longer
(4.80.6 vs. 1.60.3 y, p<0.0001) and there were fewer patients
under double anti-platelet therapy (5.9% vs. 40%, p¼0.001) in the
DES1g vs. DES2g groups. OCT identiﬁed an underlying morpholog-
ical abnormality in 95.7% of the cases, including struts signiﬁcant
malapposition (33.3%), ruptured neoatherosclerotic lesion (14.5%),
stent major underexpansion (13%), coronary evaginations (13%),
isolated struts uncoverage (11.6%), neointimal hyperplasia with
thrombus (4.3%) and edge related disease progression (4.3%).
Ruptured neoatherosclerotic lesions were more frequently observed
in DES1g than in DES2g (26.5 vs. 2.9%, p<0.01) but there was no
signiﬁcant difference between groups regarding the other abnor-
malities (including coronary evaginations). Furthermore, there was
no signiﬁcant difference regarding the percentage of malapposed
struts (7.9 vs. 7.1%) and uncovered struts (29.2 vs. 35.8 %) between
groups.
CONCLUSIONS In this prospective registry, DES thrombosis
mainly occurred  1 year after initial procedure and involved 1stand 2nd generation DES. Ruptured neoatherosclerosis was more
frequent in DES1g than in DES2g group, but this observation
might be related to the longer delay between initial PCI and ST
in paclitaxel- or sirolimus-eluting stents patients compared to
the others.
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The Impact of Plaque Morphology and Malapposition Area on Late Phase
Stent Malapposition: Insight From Optimal Coherence Tomography
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BACKGROUND Although the occurrence of stent-malapposition (SM)
after percutaneous coronary intervention (PCI) has been reduced
in accordance of progress of imaging device, late acquired stent-
malapposition (LASM) is still a well-recognized problem. Previous
studies suggested late phase SM can be a substrate for (very) late stent
thrombosis. However, the predictors are still unclear. We clariﬁed the
predictors of late phase SM, and evaluated the relation between late
phase SM and in-stent thrombus (IS-Th) by optical coherence to-
mography (OCT).
METHODS PRASFIT-Elective is a multicenter, parallel-group study
of PCI patients receiving either prasugrel or clopidogrel, in addition
to aspirin. 85 lesions in 73 patients were enrolled for serial OCT
sub-study. All lesions were performed pre-, post-PCI, and 8-mo
follow-up OCT analysis, and quantitative coronary angiography
analysis (QCA). Lipid index (averaged lipid arclipid length), ﬁbrous
cap thickness (FCT), and max arc of macrophage inﬁltration were
measured before PCI, and the total area of acute SM and IS-Th post
PCI were analyzed in association with late phase SM at 8-mo OCT.
Platelet reactivity, P2Y12 Reactive Unit (PRU) was measured at
8-mo.
RESULTS Acute SM was observed in 40 lesions (47.1%), and 13
lesions (32.5%) of them showed persistent SM and others were
resolved SM at 8-mo. Logistic regression analysis revealed the
total area of acute SM was an independent factor for persistent
SM (p¼0.037). LASM was observed in 17 lesions (20.0%). The size,
vulnerability, and inﬂammation of lipid plaque were independent
risk factors for LASM (Figure). In 8-mo OCT analysis, late phase
SM was associate with persistent IS-Th (p¼0.004) (Table). There
was no differences in PRU among resolved, persistent, and late
acquired SM (PRU:191.8082.18 vs. 141.25101.51 vs. 199.8182.96
p¼NS).
